Search Login Register

3-hydroxyphenyltrimethylammonium Summary

Description: RN given refers to parent cpd; structure

Also Known As: 3-hydroxyphenyltrimethylammonium bromide; 3-hydroxyphenyltrimethylammonium bromide, 14C-labeled; 3-hydroxyphenyltrimethylammonium iodide; PTMA; 3-hydroxy-N,N,N-trimethylbenzenaminium

Networked: 35 relevant articles (1 outcomes, 10 trials/studies) for this Bio-Agent

Key Diseases for which 3-hydroxyphenyltrimethylammonium is Relevant

  1. Mitral Valve Insufficiency (Mitral Regurgitation) : 1 outcome 3 studies in 10 results
  2. Neoplasms (Cancer) : 2 studies in 11 results
  3. Osteoporosis : 2 studies in 2 results
  4. Prostatic Neoplasms (Prostate Cancer) : 1 study in 2 results
  5. Neurodegenerative Diseases (Neurodegenerative Disease) : 1 study in 1 result
Show All >>

Drugs Related to 3-hydroxyphenyltrimethylammonium

  1. Carbon Monoxide
  2. prothymosin alpha
  3. Complementary DNA (cDNA)
  4. Messenger RNA (mRNA)
  5. Proteins (Proteins, Gene)
  6. glucuronyl glucosamine glycan sulfate (Vessel)
  7. Clusterin
  8. Biotinidase
  9. Small Interfering RNA (siRNA)
  10. 1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)
Show All >>

Therapies Related to 3-hydroxyphenyltrimethylammonium

  1. Mitral Valve Annuloplasty
  2. Catheters
  3. Transplants (Transplant)
  4. Hematopoietic Stem Cell Transplantation
  5. Heterologous Transplantation (Xenotransplantation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.